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Abstract. Although not ideal for all situations, provider volume is par-
ticularly suited for measuring surgical quality in certain contexts. Spe-
cifically, we believe that for uncommon operations with a strong volumes–
outcome effect, provider volume may be the most informative perfor-
mance measure. Because of the relative ease of determining provider
volume, it will continue to be used in value-based purchasing and public
reporting efforts. With increasing momentum from outside the profession
of surgery, it is particularly important for surgeons to participate in
making decisions regarding situations where volume may be an appro-
priate measure of quality.
Provider experience plays a large role in determining outcomes
for many surgical procedures [1–3]. With three decades of re-
search showing variations in mortality rates between high- and
low-volume providers, it is surprising that until recently very little
has been done to concentrate surgery in high-volume hospitals.
Over the past few years, however, there has been increased
interest in using provider volume as a measure of quality. For
certain operations, existing health policy efforts are focused on
selectively referring patients to high-volume hospitals [4].
Given the growing interest in this area, we sought to review the
evidence linking hospital volume to outcomes, discuss new evi-
dence regarding the importance of individual surgeon volume,
and describe current health policy efforts that focus on using
provider volume as a quality measure. We then considered the
advantages and disadvantages of using provider volume to mea-
sure surgical quality.
Hospital Volume and Mortality
Two recent structured literature reviews provide a comprehensive
picture of the large body of evidence linking volume to outcome
[1, 2]. In the first review, Dudley and colleagues identified all
studies published over 10-year period (1988–1998) investigating
hospital volume and mortality for numerous surgical and medical
conditions [2]. After excluding poor quality studies, 72 articles
addressing 40 different procedures and diagnoses were identified.
For the purposes of this review, we will limit the discussion to
operations within vascular and general surgery. For vascular
surgery, there were three operations represented (carotid end-
arterectomy, abdominal aneurysm repair, and lower extremity
bypass) and 19 of 23 studies (83%) showed a positive relationship
between volume and outcome (16 were statistically significant and
3 showed a trend). Within general surgery, there were 10 oper-
ations represented, and 34 of 34 (100%) studies showed a positive
relationship between volume and outcome (28 were statistically
significant and 6 showed a trend).
In the second review, Halm and colleagues identified volume–
outcome studies published over a 20-year period (1980–2000) [1].
Of 272 studies reviewed, 135 met the inclusion criteria that were
based largely on methodogical rigor of the studies. We have ab-
stracted the data for all studies relevant to vascular and general
surgery (Table 1). In general, the results were similar to the
previous review, with most studies showing a strong positive effect
of increasing volume on improved mortality. In addition, this
review included the magnitude of the effect (differences in mor-
tality between high- and low-volume hospitals), which varied
depending on the procedure. For instance, carotid endarterec-
tomy and colon resection have very small effects, with some
studies showing no effect, whereas for pancreatic and esophageal
resection, almost all studies show an effect and the absolute dif-
ference in mortality are on the order of 12.0%–13.0% (Table 1).
Although these reviews provide a balanced overview of the
existing literature, it is worth considering one individual study in
more detail. In the largest and most comprehensive volume–
outcome study, Birkmeyer and colleagues investigated 14 opera-
tions in the U.S. Medicare population [3]. Consistent with the
reviews cited above, they found a significant effect of volume on
outcome for all the procedures. However, the strength of the
relationship between hospital volume and mortality was also
shown to vary extensively, depending on the specific operation.
The absolute differences in operative mortality between the
highest volume and the lowest volume hospitals ranged from
12.5% for pancreatic resection to 0.2% for carotid endarterectomy
(Fig. 1).
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Most studies of the effect of volume on outcome are criticized
because they are conducted using administrative data [1–3].
Compared to prospective, clinical data registries, administrative
data sources have less clinical detail available for risk-adjustment.
As a result, it is argued that differences in mortality rates between
high- and low-volume hospitals may be due to residual differences
in patient characteristics [5, 6]. There are two reasons why this
scenario is unlikely. First, many studies using clinical data have
also shown a significant effect of volume on outcome [1, 7, 8].
Second, the ‘‘null’’ volume–outcome investigations that use rig-
orous clinical risk-adjustment also show no effect without risk-
adjustment [6]. If the lack of a volume–outcome effect were due
to more detailed clinical risk-adjustment, there would be a dif-
ference in the unadjusted outcomes between high- and low-vol-
ume hospitals. The difference in unadjusted outcomes should
disappear after taking into account the additional clinical vari-
ables. It is possible that the estimates of volume–outcome effects
would be different using more detailed risk-adjustment, but there
are no data to support the notion that the effects will disappear
entirely.
Taking all this evidence into account, two important general-
izations can be drawn. First, it is clear that hospital volume is
important in determining operative mortality. The large numbers
of studies coming to the same conclusion make this fact difficult
to refute. Second, it is also clear that uncommon, high-risk cancer
procedures (e.g., pancreatic and esophageal resection) have much
larger effects than more common operations (e.g., colon resection
and coronary artery bypass grafting). What is less clear is exactly
how to translate this information into policy that helps patients
and improves the overall quality of surgical care. We consider the
strengths and limitations of using hospital volume as a quality
indicator in a future section of this review.
Studying the relationship between hospital volume and mor-
tality may be useful for reasons other than selective referral
policies. High-volume hospitals are likely adhere to certain pro-
cesses of care that lead to superior outcomes, but very few of
these fine details of surgical care are known. Identifying process
measures that contribute to variations in surgical outcomes will be
a necessary step in improving the overall quality of surgical care.
Indeed, for medical conditions, such as acute myocardial infarc-
tion, studies have shown that existing hospital-level variations in
mortality are mediated through the appropriate use of aspirin and
beta-blockers [9]. Although similar studies in surgical populations
will help identify ways for hospitals to improve, it is not clear that
even a complete inventory of these processes of care will raise
low-volume hospitals to the same level of performance as high-
volume hospitals.
Surgeon Volume and Patient Mortality
Largely because hospital volume is more easily determined, many
previous studies have not considered the role of individual sur-
geon volume. In the review by Halm and colleagues, a much













for high vs low
volume (range)
Vascular operations
Carotid endarterectomy 15 (7) 10 (5–50) 50 (21–100) 1.8 (0.9–2.3) 0.4 ().05–1.8)
Elective abdominal
aneurysm repair
8 (7) 12 (3–31) 36 (12–433) 7.5 (3.8–7.6) 3.3 (1.1–11.6)
Ruptured abdominal aneurysm
repair
8 (2) 9 (2–10) 20 (5–50) 49.8 (40.0–63.2) 7.9 (1.5–18.7)
Lower extremity arterial bypass 2 (1) 13 and 20 32 and 100 3.1 and 3.8 1.1 and 1.4
General surgery operations
Pancreatic resection 10 (9) 5 (1–22) 20 (3–200) 9.7 (5.8–12.9) 13.0 (3.0–17.9)
Esophageal resection 3 (3) 5 (5–10) 30 (11–200) 13.9 (8.9–14.0) 12.0 (11.0–13.9)
Breast cancer surgery 1 (1) 10 151 NA a
Colorectal resection 10 (4) 18 (10–84) 115 (18–253) 6.0 (3.5–12.3) 1.9 ()1.2–9.7)
Gastric resection 3 (1) 10 (5–15) 63 (15–201) 10.9 6.5 (4.0–7.1)
aResults were reported in terms of 5-year survival. In this study, patients in the lowest-volume hospitals had a 60% higher risk of death within 5 years
than those at high-volume hospitals.
Source: Modified from Halm et al. [1]
Fig. 1. Absolute mortality differences between very high and very low
volume hospitals for general and vascular surgery. Based on national
Medicare data and Birkmeyer et al. [2].
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shorter list of studies investigated the impact of surgeon volume.
For those operations where surgeon volume was considered, most
also showed a significant effect on mortality [1]. Few of these
studies, however, had sufficient sample size or used appropriate
multi-level modeling methods to determine the relative impact of
hospital and surgeon volume in contributing to low operative
mortality.
In a recent study using the national Medicare population from
1998–1999, Birkmeyer and colleagues overcame many of the
limitations of previous studies of surgeon volume and outcomes.
The authors found that surgeon volume was a strong independent
predictor of operative mortality for all eight operations consid-
ered [10]. Figure 2 shows the impact of surgeon volume on
mortality for four general and vascular operations before and
after adjusting for the effect of hospital volume. Interestingly,
hospital volume accounted for a variable proportion of the ob-
served surgeon volume effect. With carotid endarterectomy, for
example, none of the effect is attributable to hospital volume. For
other operations, hospital volume accounts for up to one half of
the surgeon volume effect. This finding has strong face validity,
since carotid endarterectomy requires few resources beyond the
skill of the individual surgeon. In contrast, abdominal aortic
aneurysm repair requires optimal functioning of a broad range of
resources (e.g., anesthesia staff and intensive care units). Given
the strong independent effect of individual surgeon volume on
mortality, especially for certain operations, it is likely to play a
larger role in future efforts to measure quality.
Efforts to Incorporate Provider Volume into Health Policy
Provider volume is currently at the center of health policy efforts
aimed at improving the quality of surgical care. The theoretical
goals of releasing quality information, such as provider volume, to
the public are threefold: (1) patients will be able to choose the
best hospitals; (2) payers will create incentives that direct patients
to the best hospitals; and (3) providers will use the information to
direct quality improvement activities. As a quality indicator,
provider volume is most directly applicable to the first two of
these objectives. But provider volume can also serve a useful role
in quality improvement. If the processes of care that enable high-
volume providers to have the best outcomes can be isolated (‘‘best
practices’’), these can be exported to other settings and improve
the care at all hospitals. However, the use of volume in this
quality-improvement capacity has taken a back seat to the selec-
tive referral efforts.
Largely because hospital volume is easily determined from
readily available administrative data, it is central to several
public-reporting initiatives. Table 2 shows an illustrative but not
exhaustive list of public reporting efforts that include hospital
volume. Using national administrative databases, a growing
number of proprietary Internet sites now provide hospital vol-
ume for many operations (e.g., Healthgrades.com). In addition,
the Agency for Healthcare Research and Quality has included
the hospital volume of several surgical procedures in their
Inpatient Quality Indicators [11]. These quality indicators have
subsequently been used by payers (e.g., Blue Cross Blue Shield
in New York State) and state health organizations (e.g., Texas
Inpatient Hospital Association) for public reporting of volume.
However, despite the increasing availability of information on
hospital volume, the public doesnt seem to be using it to help
choose hospitals [12–14]. Future investigations should explore
how patients go about choosing hospitals and try to determine
why most ignore hospital report cards. Is it because they dont
know about the report cards? Or is it because they prefer to go
to a local hospital?
Another use of publicly available information on quality is
gaining momentum: health care payers are seeking to selectively
contract with providers based on the quality of care they provide
(value-based purchasing). As the most visible of these efforts, the
Leapfrog Group represents many large employers interested in
creating incentives that result in directing more patients to the
highest quality hospitals [4]. The Leapfrog Groups initial patient
safety practices recommended selective referral to high-volume
hospitals for five procedures: coronary artery bypass grafting,
percutaneous coronary interventions, esophageal resection,
abdominal aortic aneurysm repair, and carotid endarterectomy.
It should be noted that several recent changes have been made
in the 2003 Leapfrog standards (Table 3). In the updated stan-
dards, carotid endarterectomy has been dropped from the list,
largely because of the very small hospital volume effect. In con-
trast, pancreatic resection has been added because of many
studies documenting a strong relationship between volume and
outcomes. Also in the updated standards, there has been a shift
toward incorporating more than volume standards. The use of
perioperative beta-blockade (a process measure) has been added
for abdominal aortic aneurysm repair. Hospitals must demon-
strate that at least 80% of patients receive beta-blockers to be fully
compliant. Also in the new standards, full compliance for coro-
nary artery bypass grafting requires demonstrating low risk-ad-
justed mortality rates either in those states with existing public
reporting efforts (NY, NJ, PA, CA) or through the use of the
Society of Thoracic Surgeons database.
Fig. 2. Effect of surgeon volume on mortality before and after adjusting
for hospital volume. From these analyses, the proportion of the surgeon
volume effect attributable to hospital volume can be estimated. Data from
the National Medicare database, modified from Birkmeyer et al. [10].
Dimick et al.: Measuring Surgical Quality 1219
Strengths and Weaknesses of Provider Volume as a Quality
Indicator
Using provider volume as a proxy for quality has several advan-
tages compared to other approaches. First, volume is easily
determined from readily available data sources. In contrast, direct
outcomes measurement requires detailed clinical data that are not
widely available. Second, provider volume is meaningful to pa-
tients. Unlike many complex quality measures used in some hos-
pital report cards, patients can grasp the value of ‘‘experience’’
with a specific procedure. Finally, another advantage is the relative
usefulness of provider volume compared to other measures for
operations that are infrequently performed. Many operations are
not done often enough to generate the sample sizes needed to
estimate precise mortality and morbidity rates for individual hos-
pitals. This limitation is particularly important when considering
the specific context where quality may be measured best using
provider volume. For instance, the quality of uncommon opera-
tions with a strong volume–outcome effect, such as pancreatic
resection and esophageal resection, may be most optimally mea-
sured using hospital or surgeon volume. Most hospitals perform
only a few of these procedures each year, and directly measuring
outcomes for these operations is therefore not possible.
The chief limitation of provider volume as a quality measures it
that the relationship between volume and outcome only holds true
on average [15]. Thus, provider volume does not work well for
predicting the quality of individual hospitals or surgeons. For an
operation that is performed often enough for mortality rates to
provide precise estimates of mortality rates, such as coronary ar-
tery bypass grafting, this shortcoming is particularly evident. One
recent study of coronary artery bypass surgery demonstrated that
85% of low-volume and 89% of medium-volume hospitals had
mortality rates that were no different from the national average
[16]. In addition, only 11% of high-volume hospitals had mortality
rates that were statistically lower than the average. However, be-
cause hospitals perform hundreds of cases of coronary artery by-
pass each year, this may be the only operation where it is feasible
to use risk-adjusted mortality rates to measure performance.
When considering the goal of quality improvement, another
limitation of volume becomes apparent. In contrast to measuring
outcomes or processes, volume is not actionable from the pro-
viders perspective. When providers have poor outcomes or low
rates of adherence to an important process of care, they can seek
to correct the underlying problems. Any efforts to unnecessarily
increase volume may result in more inappropriate operations,
especially for more discretionary operations. From a patient and
payer perspective, however, volume is actionable. Public reporting
and pay-for-performance initiatives will direct patients toward
better hospitals and result in a net reduction in mortality rates.
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